Investors Ride 5 Healthcare Earnings Rollercoaster Rides

Alere Inc. (NYSE:ALR) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 31.17% to $0.53 in the quarter versus EPS of $0.77 in the year-earlier quarter. Revenue Rose 10.14% to $739.2 million from the year-earlier quarter.

Alere Inc. reported adjusted EPS income of $0.53 per share. By that measure, the company beat the mean analyst estimate of $0.51. It beat the average revenue estimate of $727.66 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ALR

BioScrip, Inc. (NASDAQ:BIOS) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.04 in the quarter versus EPS of $-0.04 in the year-earlier quarter. Revenue Rose 27.91% to $199.07 million from the year-earlier quarter.

BioScrip, Inc. reported adjusted EPS income of $0.04 per share. By that measure, the company beat the mean analyst estimate of $0.02. It beat the average revenue estimate of $189.36 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BIOS

Metabolix, Inc. (NASDAQ:MBLX) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.2 in the quarter versus EPS of $0.84 in the year-earlier quarter. Revenue Decreased 95.07% to $1.94 million from the year-earlier quarter.

Metabolix, Inc. reported adjusted EPS loss of $0.2 per share. By that measure, the company beat the mean analyst estimate of $-0.22. It beat the average revenue estimate of $1.43 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MBLX

Sangamo Biosciences Inc. (NASDAQ:SGMO) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.13 in the quarter versus EPS of $-0.14 in the year-earlier quarter. Revenue Rose 41.98% to $4.6 million from the year-earlier quarter.

Sangamo Biosciences Inc. reported adjusted EPS loss of $0.13 per share. By that measure, the company beat the mean analyst estimate of $-0.16. It beat the average revenue estimate of $3.79 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

SGMO

Halozyme Therapeutics, Inc. (NASDAQ:HALO) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.17 in the quarter versus EPS of $-0.14 in the year-earlier quarter. Revenue Rose 59.01% to $11.83 million from the year-earlier quarter.

Halozyme Therapeutics, Inc. reported adjusted EPS loss of $0.17 per share. By that measure, the company missed the mean analyst estimate of $-0.15. It beat the average revenue estimate of $7.05 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

HALO

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , ,  

More from The Cheat Sheet